glp-1 food news GLP-1s—more commonly known by brand names like Ozempic, Zepbound, and Wegovy—are affecting the way we eat. But companies are already figuring out ways to serve a new, less-hungry customer. A growing What to know about packaged

They don't want to worry about remembering, 'OK, it's this week, and I have to take it the following week.' So it's just easier to fit into your life when you have a pill," ABC News chief medical correspondent Dr

OSU: Data on file

CONCLUSIONS CONFLICTS OF INTEREST In the last 5 years Adie Viljoen has received lecture honoraria and/or travel support and/or conducts clinical trials funded by: Amarin, Amgen, Astra Zeneca, Boehringer Ingleheim, Daiichi-Sankyo, Lilly, Menarini, NewAmsterdam, Novartis, Novo Nordisk, Pfizer, Regeneron, Sanofi, Takeda, and Tosoh

Additionally, about one-fifth of adults who use GLP-1 agonists reported having experienced vomiting